查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2061423

冷凍消融設備市場：商業機會、成長要素、產業趨勢分析及 2026-2035 年預測。

Cryoablation Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，全球冷凍消融設備市場價值將達到 5.153 億美元，年複合成長率為 8.3%，到 2035 年將達到 11 億美元。

冷凍消融設備市場-IMG1

推動市場成長的因素包括癌症和心血管疾病的發病率上升、人們對微創治療方法日益青睞以及冷凍消融系統的持續技術的進步。人口老化、久坐的生活方式以及肥胖和糖尿病等風險因素的增加，進一步加劇了疾病的流行和治療需求。冷凍消融設備是一種醫療技術，旨在透過專用探針或導管施加低溫來去除異常或病變組織。這些系統能夠創建可控的冷凍區域，精準靶向腫瘤或心臟組織，同時保護周圍健康組織。其高安全性以及能夠提供標靶治療並縮短恢復時間，使其廣泛應用於微創腫瘤和心臟病手術。臨床上對併發症率低、可重複性高、患者預後改善等優勢的手術方式的偏好日益成長，這顯著促進了其在全球醫療系統中的應用。隨著醫療機構不斷轉向微創治療方法，預計全球市場對冷凍消融技術的需求將保持強勁。

市場範圍
開始年份 2025
預測期 2026-2035
初始市場規模 5.153億美元
預測金額 11億美元
複合年成長率 8.3%

到2025年，探針類產品將佔據72%的市場。冷凍消融探針是輸送低溫的主要器械，可在心臟和腫瘤治療中實現精準可控的組織消融。這些器械有多種配置，包括長度、直徑和尖端結構等方面的差異，使醫生能夠根據特定的解剖結構和臨床需求定製手術方案。探針設計的不斷進步，例如導熱性能的提升和冷凍性能的最佳化，正在提高手術的精準度、一致性和整體治療效果，從而推動該領域的持續成長。

截至2025年，腫瘤治療領域將佔51.5%的市場。該領域專注於利用冷凍消融技術治療各種癌症，包括肝癌、腎癌、肺癌、前列腺癌和乳腺癌。冷凍消融技術能夠精準地破壞惡性組織，同時最大限度地減少對周圍健康組織的損傷，因此對於不適合傳統手術的患者尤其適用。隨著臨床醫生擴大採用微創腫瘤治療方案，冷凍消融技術的應用範圍在根治性治療和安寧療護方面都在不斷擴大。

美國冷凍消融設備市場預計到2025年將達到1.903億美元，並在2026年至2035年間以8%的複合年成長率成長。北美癌症患者數量的不斷增加是推動冷凍消融技術需求的主要因素。該地區每年的癌症診斷率居高不下，因此對先進的微創治療方案的需求日益成長。此外，臨床上對精準腫瘤管理技術的日益青睞也進一步促進了市場擴張。

目錄

第1章：調查方法

第2章執行摘要

第3章 行業洞察

  • 產業生態系分析
  • 影響產業的因素
    • 促進因素
      • 癌症和心血管疾病發生率增加
      • 對微創手術的需求日益成長
      • 冷凍消融設備的技術進步
      • 政府措施和宣傳宣傳活動增加
    • 產業潛在風險與挑戰
      • 冷凍消融設備高成本
      • 缺乏意識和專業知識
    • 市場機遇
      • 擴大冷凍消融術在疼痛管理的臨床證據
  • 成長潛力分析
  • 監理情勢
  • 技術展望
    • 最新科技趨勢
      • 高階成像整合
      • 多通道和溫度監控系統
    • 新興技術
      • 液態氮基系統
      • 開發新的臨床應用
  • 未來市場趨勢
  • 人工智慧和生成式人工智慧對市場的影響
  • 價格趨勢分析
  • 波特的分析
  • PESTLE分析

第4章 競爭情勢

  • 介紹
  • 企業市佔率分析
    • 世界
    • 北美洲
    • 歐洲
    • 亞太地區
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 主要進展
    • 併購
    • 夥伴關係和聯盟
    • 新產品發布
    • 業務拓展計劃

第5章 市場估計與預測：依類型分類，2022-2035年

  • Probe
    • 組織接觸探針消融器
    • 表皮和皮下冷凍切除系統
    • 組織噴霧式探針消融器
  • 系統
    • 發電機
    • 配件和耗材

第6章 市場估計與預測：依應用領域分類，2022-2035年

  • 循環系統
  • 腫瘤學
    • 肺癌
    • 乳癌
    • 肝癌
    • 腎癌
    • 攝護腺癌
  • 其他用途

第7章 市場估計與預測：依最終用途分類，2022-2035年

  • 醫院
  • 門診手術中心
  • 專業醫療中心
  • 其他最終用戶

第8章 市場估計與預測：依地區分類，2022-2035年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE

第9章：公司簡介

  • Adagio Medical
  • AtriCure Inc.
  • Boston Scientific
  • CooperSurgical
  • CPSI Biotech
  • Endocare（HealthTronics）
  • Erbe Elektromedizin
  • Hygea Medical
  • IceCure Medical
  • Inomed Medizintechnik
  • Medtronic
  • Monteris Medical
  • METRUM Cryoflex
  • Varian Medical Systems
  • IceSense Medical
簡介目錄
Product Code: 6025

The Global Cryoablation Devices Market was valued at USD 515.3 million in 2025 and is estimated to grow at a CAGR of 8.3% to reach USD 1.1 billion by 2035.

Cryoablation Devices Market - IMG1

The market growth is driven by the rising incidence of cancer and cardiovascular diseases, increasing preference for minimally invasive treatment procedures, and continuous technological advancements in cryoablation systems. Expanding aging populations, sedentary lifestyles, and higher exposure to risk factors such as obesity and diabetes are further contributing to disease prevalence and treatment demand. Cryoablation devices are medical technologies designed to eliminate abnormal or diseased tissue through the application of extremely low temperatures delivered via specialized probes or catheters. These systems generate controlled freezing zones that precisely target tumors or cardiac tissue while protecting surrounding healthy structures. They are widely used in minimally invasive oncology and cardiology procedures due to their ability to deliver targeted therapy with improved safety and reduced recovery time. Growing clinical preference for procedures that offer lower complication rates, repeatability, and enhanced patient outcomes is significantly strengthening adoption across healthcare systems worldwide. As healthcare providers continue to shift toward less invasive treatment alternatives, demand for cryoablation technologies is expected to remain strong across global markets.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$515.3 Million
Forecast Value$1.1 Billion
CAGR8.3%

The probe segment accounted for a share of 72% in 2025. Cryoablation probes serve as the primary delivery instruments for extremely low temperatures, enabling precise and controlled tissue destruction in both cardiac and oncology applications. These devices are available in multiple configurations, including varying lengths, diameters, and tip structures, allowing physicians to tailor procedures to specific anatomical and clinical needs. Ongoing advancements in probe design, including improved thermal conductivity and optimized freezing performance, are enhancing procedural accuracy, consistency, and overall treatment outcomes, thereby supporting sustained segment growth.

The oncology segment held a share of 51.5% in 2025. This segment focuses on the use of cryoablation technologies for treating a range of cancers, including tumors affecting the liver, kidney, lung, prostate, and breast. Cryoablation enables targeted destruction of malignant tissues while minimizing damage to surrounding healthy structures, making it particularly valuable for patients who are not eligible for traditional surgical interventions. Its application across both curative and palliative care settings continues to expand as clinicians increasingly adopt minimally invasive oncology treatment options.

U.S. Cryoablation Devices Market was valued at USD 190.3 million in 2025 and is projected to grow at a CAGR of 8% from 2026 to 2035. The rising burden of cancer cases across North America is a major factor fueling demand for cryoablation technologies. The region continues to record a high volume of annual cancer diagnoses, reinforcing the need for advanced and minimally invasive treatment solutions. Increasing clinical preference for precise tumor management techniques is further supporting market expansion.

Key companies operating in the Global Cryoablation Devices Market include Medtronic, Boston Scientific, AtriCure Inc., Varian Medical Systems, IceCure Medical, Monteris Medical, Erbe Elektromedizin, Adagio Medical, CooperSurgical, CPSI Biotech, Endocare (HealthTronics), Hygea Medical, Inomed Medizintechnik, METRUM Cryoflex, and IceSense Medical. Companies in the cryoablation devices market are focusing on strengthening their market position through continuous technological innovation aimed at improving precision, safety, and procedural efficiency. A key strategy involves expanding product portfolios with next-generation cryoprobes and integrated ablation systems that offer enhanced thermal control and better clinical outcomes. Market players are also investing heavily in research and development to advance imaging-guided cryoablation and improve real-time procedural monitoring capabilities. Strategic collaborations with hospitals, oncology centers, and research institutions are helping accelerate clinical adoption and expand procedural applications. Additionally, companies are pursuing regulatory approvals in multiple regions to broaden geographic reach and increase commercialization opportunities. Strengthening distribution networks and expanding presence in emerging healthcare markets are also key priorities.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research approach
  • 1.2 Quality commitments
    • 1.2.1 GMI AI policy and data integrity commitment
      • 1.2.1.1 Source consistency protocol
  • 1.3 Research trail and confidence scoring
    • 1.3.1 Research trail components
    • 1.3.2 Scoring components
  • 1.4 Data collection
    • 1.4.1 Partial list of primary sources
  • 1.5 Data mining sources
    • 1.5.1 Paid sources
      • 1.5.1.1 Sources, by region
  • 1.6 Base estimates and calculations
    • 1.6.1 Base year calculation for any one approach
  • 1.7 Forecast model
    • 1.7.1 Quantified market impact analysis
      • 1.7.1.1 Mathematical impact of growth parameters on forecast
  • 1.8 Research transparency addendum
    • 1.8.1 Source attribution framework
    • 1.8.2 Quality assurance metrics
    • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Type trends
    • 2.2.2 Application trends
    • 2.2.3 End use trends
    • 2.2.4 Regional trends
  • 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cancer & cardiovascular disorders.
      • 3.2.1.2 Growing demand for minimally invasive procedures.
      • 3.2.1.3 Technological advancements in cryoablation devices.
      • 3.2.1.4 Rising government initiatives and awareness campaigns.
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost associated with cryoablation devices.
      • 3.2.2.2 Lack of awareness and expertise.
    • 3.2.3 Market opportunities
      • 3.2.3.1 Expanding clinical evidence for cryoablation in pain management
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape (Driven by primary research)
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East and Africa
  • 3.5 Technology landscape (Driven by primary research)
    • 3.5.1 Current technological trends
      • 3.5.1.1 Advanced imaging integration
      • 3.5.1.2 Multi-channel and temperature monitoring systems
    • 3.5.2 Emerging technologies
      • 3.5.2.1 Liquid nitrogen-based systems
      • 3.5.2.2 Expansion into new clinical applications
  • 3.6 Future market trends (Driven by primary research)
  • 3.7 Impact of AI and Generative AI on the market (Driven by primary research)
  • 3.8 Pricing trend analysis (Driven by primary research)
  • 3.9 Porter’s analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 Global
    • 4.2.2 North America
    • 4.2.3 Europe
    • 4.2.4 Asia Pacific
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers and acquisitions
    • 4.6.2 Partnerships and collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Type, 2022 - 2035 ($ Mn)

  • 5.1 Key trends
  • 5.2 Probe
    • 5.2.1 Tissue contacts probe ablators
    • 5.2.2 Epidermal and subcutaneous cryoablation systems
    • 5.2.3 Tissue spray probe ablators
  • 5.3 Systems
    • 5.3.1 Generator
    • 5.3.2 Accessories & consumables

Chapter 6 Market Estimates and Forecast, By Application, 2022 - 2035 ($ Mn)

  • 6.1 Key trends
  • 6.2 Cardiology
  • 6.3 Oncology
    • 6.3.1 Lung cancer
    • 6.3.2 Breast cancer
    • 6.3.3 Liver cancer
    • 6.3.4 Kidney cancer
    • 6.3.5 Prostate cancer
  • 6.4 Other applications

Chapter 7 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Specialty centers
  • 7.5 Other end users

Chapter 8 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Spain
    • 8.3.5 Italy
    • 8.3.6 Netherlands
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE

Chapter 9 Company Profiles

  • 9.1 Adagio Medical
  • 9.2 AtriCure Inc.
  • 9.3 Boston Scientific
  • 9.4 CooperSurgical
  • 9.5 CPSI Biotech
  • 9.6 Endocare (HealthTronics)
  • 9.7 Erbe Elektromedizin
  • 9.8 Hygea Medical
  • 9.9 IceCure Medical
  • 9.10 Inomed Medizintechnik
  • 9.11 Medtronic
  • 9.12 Monteris Medical
  • 9.13 METRUM Cryoflex
  • 9.14 Varian Medical Systems
  • 9.15 IceSense Medical